Methylenedioxypyrovalerone-d8 Hydrochloride
- CAS No.
- 1246820-09-6
- Chemical Name:
- Methylenedioxypyrovalerone-d8 Hydrochloride
- Synonyms
- MDPV-d8;MDPV-D8 HCl;3,4-Methylenedioxy Pyrovalerone-d8;3,4-Methylenedioxypyrovalerone-D8.HCl;Methylenedioxypyrovalerone-d8 Hydrochloride;1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl-d8)-;3,4-Methylenedioxypyrovalerone-d8 hydrochloride;3,4-Methylenedioxypyrovalerone-d8 HCl (MDPV-d8 HCl) solution;3,4-Methylenedioxypyrovalerone-D8.HCl, 1mg/ml in Methanol (as free base);3,4-Methylenedioxypyrovalerone-D8.HCl, 0.1mg/ml in Methanol (as free base)
- CBNumber:
- CB42510965
- Molecular Formula:
- C16H22ClNO3
- Molecular Weight:
- 311.80378
- MDL Number:
- MOL File:
- 1246820-09-6.mol
- MSDS File:
- SDS
| Melting point | 227-229C |
|---|---|
| Flash point | 9℃ |
| storage temp. | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
| solubility | DMF: 0.25 mg/ml; DMSO: 0.1 mg/ml; Ethanol: 1 mg/ml; PBS (pH 7.2): 10 mg/ml |
| form | A crystalline solid |
| Stability | Hygroscopic |
| Major Application | pharmaceutical (small molecule) |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() ![]() ![]() GHS02,GHS06,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H301+H311+H331-H370 | |||||||||
| Precautionary statements | P210-P260-P280-P301+P310-P311 | |||||||||
| Hazard Codes | F,T | |||||||||
| Risk Statements | 11-23/24/25-39/23/24/25 | |||||||||
| Safety Statements | 7-16-36/37-45 | |||||||||
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution | |||||||||
| WGK Germany | 1 | |||||||||
| Storage Class | 3 - Flammable liquids | |||||||||
| Hazard Classifications | Eye Irrit. 2 Flam. Liq. 2 |
|||||||||
| NFPA 704 |
|
Methylenedioxypyrovalerone-d8 Hydrochloride price More Price(11)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | M-150 | 3,4-Methylenedioxypyrovalerone-d8 HCl (MDPV-d8 HCl) solution 100?μg/mL in methanol (as free base), ampule of 1?mL, certified reference material, Cerilliant? | 1246820-09-6 | 1ML | $246 | 2026-04-30 | Buy |
| Cayman Chemical | 10679 | 3,4-Methylenedioxy Pyrovalerone-d8 (hydrochloride) ≥99%deuteratedforms(d1- |
1246820-09-6 | 1mg | $90 | 2026-04-30 | Buy |
| Cayman Chemical | 10679 | 3,4-Methylenedioxy Pyrovalerone-d8 (hydrochloride) ≥99%deuteratedforms(d1- |
1246820-09-6 | 5mg | $176 | 2026-04-30 | Buy |
| Cayman Chemical | 10679 | 3,4-Methylenedioxy Pyrovalerone-d8 (hydrochloride) ≥99%deuteratedforms(d1- |
1246820-09-6 | 10mg | $336 | 2026-04-30 | Buy |
| TRC | TRC-M304082-5MG | MDPV-d8 | 1246820-09-6 | 5mg | $613 | 2026-06-03 | Buy |
Methylenedioxypyrovalerone-d8 Hydrochloride Chemical Properties, Uses, Production
Description
3,4-Methylenedioxy Pyrovalerone-
Chemical Properties
White Solid
Uses
Labelled Methylenedioxypyrovalerone (MDPV; Cat. # M304080) as a central nervous system
Uses
Labelled Methylenedioxypyrovalerone (M304080) as a central nervous system
References
[1] CATHERINE HéRON Jean J B Jean Costentin. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier[J]. European journal of pharmacology, 1994, 264 3: Pages 391-398. DOI: 10.1016/0014-2999(94)00502-8
[2] De Souza, F.I., Zumiotti, A.V., and Da Silva, C.F. Neuregulins 1-α and 1-β on the regeneration the peripheral nerves[J]. Acta Ortop Bras.
[3] FOLKER WESTPHAL . Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: A designer drug with α-pyrrolidinophenone structure[J]. Forensic science international, 2009, 190 1: Pages 1-8. DOI: 10.1016/j.forsciint.2009.05.001
[4] MARKUS R. MEYER. Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC–MS and LC–high-resolution MS and its detectability in urine by GC–MS[J]. Journal of Mass Spectrometry, 2010, 45 12: 1426-1442. DOI: 10.1002/jms.1859
[5] KINGA FARKAS. [Clinical characteristics of 5 hospitalized 3,4-methylenedioxypyrovalerone (MDPV) users].[J]. Psychiatria Hungarica, 2013, 28 4: 431-439.
[6] SABINA STRANO-ROSSI. Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MPDV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry[J]. Rapid Communications in Mass Spectrometry, 2010, 24 18: 2706-2714. DOI: 10.1002/rcm.4692







